249 related articles for article (PubMed ID: 34408079)
41. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
[TBL] [Abstract][Full Text] [Related]
42. Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments.
Kawashima M; Kojima M; Ueda Y; Kurihara S; Hiyama E
J Pediatr Surg; 2016 Dec; 51(12):2080-2085. PubMed ID: 27793328
[TBL] [Abstract][Full Text] [Related]
43. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Min J; Wright WE; Shay JW
Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
[TBL] [Abstract][Full Text] [Related]
44. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
[TBL] [Abstract][Full Text] [Related]
45. AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.
Iyer R; Varela CR; Minturn JE; Ho R; Simpson AM; Light JE; Evans AE; Zhao H; Thress K; Brown JL; Brodeur GM
Cancer Chemother Pharmacol; 2012 Sep; 70(3):477-86. PubMed ID: 22623209
[TBL] [Abstract][Full Text] [Related]
46. Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma.
Roderwieser A; Sand F; Walter E; Fischer J; Gecht J; Bartenhagen C; Ackermann S; Otte F; Welte A; Kahlert Y; Lieberz D; Hertwig F; Reinhardt HC; Simon T; Peifer M; Ortmann M; Büttner R; Hero B; O'Sullivan RJ; Berthold F; Fischer M
JCO Precis Oncol; 2019 Dec; 3():1-20. PubMed ID: 35100718
[TBL] [Abstract][Full Text] [Related]
47. Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Celeghin A; Giunco S; Freguja R; Zangrossi M; Nalio S; Dolcetti R; De Rossi A
Cell Death Dis; 2016 Dec; 7(12):e2562. PubMed ID: 28032863
[TBL] [Abstract][Full Text] [Related]
48. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
49. ATM regulates the length of individual telomere tracts in Arabidopsis.
Vespa L; Warrington RT; Mokros P; Siroky J; Shippen DE
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18145-50. PubMed ID: 17989233
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
51. Meiotic telomere distribution and Sertoli cell nuclear architecture are altered in Atm- and Atm-p53-deficient mice.
Scherthan H; Jerratsch M; Dhar S; Wang YA; Goff SP; Pandita TK
Mol Cell Biol; 2000 Oct; 20(20):7773-83. PubMed ID: 11003672
[TBL] [Abstract][Full Text] [Related]
52. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
53. Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.
Yu EY; Cheung NV; Lue NF
J Hematol Oncol; 2022 Aug; 15(1):117. PubMed ID: 36030273
[TBL] [Abstract][Full Text] [Related]
54. GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells.
Pintado-Berninches L; Fernandez-Varas B; Benitez-Buelga C; Manguan-Garcia C; Serrano-Benitez A; Iarriccio L; Carrillo J; Guenechea G; Egusquiaguirre SP; Pedraz JL; Hernández RM; Igartua M; Arias-Salgado EG; Cortés-Ledesma F; Sastre L; Perona R
Cell Death Differ; 2019 Oct; 26(10):1998-2014. PubMed ID: 30670828
[TBL] [Abstract][Full Text] [Related]
55. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
56. Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
Jette NR; Radhamani S; Arthur G; Ye R; Goutam S; Bolyos A; Petersen LF; Bose P; Bebb DG; Lees-Miller SP
Br J Cancer; 2019 Oct; 121(7):600-610. PubMed ID: 31481733
[TBL] [Abstract][Full Text] [Related]
57. Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations.
Farooqi AS; Dagg RA; Choi LM; Shay JW; Reynolds CP; Lau LM
J Neurooncol; 2014 Aug; 119(1):17-26. PubMed ID: 24792489
[TBL] [Abstract][Full Text] [Related]
58. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
Min J; Wright WE; Shay JW
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
[TBL] [Abstract][Full Text] [Related]
59. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
60. The effect of the ATM inhibitor AZD0156 on the radiosensitivity of human breast cancer and lung fibroblast cells.
Yilmaz U; Kamer D; Asik A; Kara HG; Gündüz C; Kamer S
J Cancer Res Ther; 2023; 19(2):203-207. PubMed ID: 37006058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]